amiodarone has been researched along with uk 68798 in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (6.90) | 18.2507 |
2000's | 37 (63.79) | 29.6817 |
2010's | 15 (25.86) | 24.3611 |
2020's | 2 (3.45) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Keserü, GM | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Jia, L; Sun, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Honerjäger, P; Schmidt, G | 1 |
Bharucha, D; Kowey, PR; Marinchak, RA; Rials, SJ | 1 |
Beyer, ME; Hoffmeister, HM; Seipel, L | 1 |
MacNeil, DJ | 1 |
Sager, PT | 1 |
Alboni, P; Bianconi, L; Castro, A; Dinelli, M; Pappalardo, A; Richiardi, E; Santini, M | 1 |
Schmitt, C | 1 |
Knobloch, K; Wirth, KJ | 1 |
Camm, AJ | 1 |
Ahn, S; Etienne, J; Friedrich, T; Ghadanfar, M; Massart, PE; Pouleur, H; Rousseau, MF; van Eyll, C | 1 |
Dai, DZ; Kong, RZ; Li, HT; Wang, YQ | 1 |
Cox, CD; Tsikouris, JP | 1 |
Bianconi, L; Castro, A; Santini, M | 1 |
Cleland, JG; Deedwania, PC; Khand, AU | 1 |
Singh, BN | 1 |
Nattel, S; Schram, G; Shinagawa, K; Shiroshita-Takeshita, A | 1 |
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
Wolbrette, DL | 1 |
DeBisschop, M; Lower, DL; Martin, LG; Yamreudeewong, W | 1 |
Khan, MH | 1 |
Li, WZ | 1 |
Singh, S | 1 |
Mounsey, JP; VerNooy, RA | 1 |
Prystowsky, EN | 1 |
Corley, SD; DiMarco, JP; Domanski, MJ; Epstein, AE; Geller, N; Greene, HL; Josephson, RA; Kellen, JC; Klein, RC; Krahn, AD; Mickel, M; Mitchell, LB; Nelson, JD; Rosenberg, Y; Schron, E; Shemanski, L; Waldo, AL; Wyse, DG | 1 |
Bleich, M; Brendel, J; Busch, AE; Knobloch, K; Rosenstein, B; Wirth, KJ | 1 |
Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C | 1 |
Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J | 1 |
Bhatia, GS; Lip, GY | 1 |
Hamlin, RL; Keene, BW; Kijtawornrat, A; Nishijima, Y; Roche, BM | 1 |
Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
Afkham, F; Itter, G; Linz, DK; Rütten, H; Wirth, KJ | 1 |
London, B | 1 |
Verma, A | 1 |
Ahmad, K; Akhtari, S; Dorian, P; Korley, V; Mangat, I; Newman, D; O'Connell, T; O'Donnell, S; Pinter, A; Posan, E | 1 |
DU, CY; El Harchi, A; Hancox, JC; Orchard, CH; Zhang, YH | 1 |
Saklani, P; Skanes, A | 1 |
Anderson, JL; Bunch, TJ | 1 |
Adelstein, E; Alam, MB; Jain, SK; Khattak, F; Leef, G; Munir, MB; Patel, D; Qin, D; Rattan, R; Saba, S | 1 |
Abildgaard, L; Diness, JG; Grunnet, M; Jespersen, T; Kirchhoff, JE; Sheykhzade, M | 1 |
Dick, T; Negrelli, J; Olson, JL; Rickard, JP | 1 |
Atkins, D; Bommana, S; Carroll, H; Gopinathannair, R; Jeffrey, C; Lakkireddy, D; Natale, A; Newton, D; Nydegger, C; Sharma, SP; Turagam, M | 1 |
Árpádffy-Lovas, T; Baczkó, I; Husti, Z; Varró, A; Virág, L | 1 |
Batul, A; Bogun, F; Chugh, A; Chung, E; Crawford, T; Cunnane, R; Ghanbari, H; Ghannam, M; Jongnarangsin, K; Latchamsetty, R; Liang, J; Morady, F; Oral, H; Pelosi, F; Saeed, M; Shantha, G | 1 |
21 review(s) available for amiodarone and uk 68798
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Phenethylamines; Sotalol; Sulfonamides | 1997 |
The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Conduction System; Heart Failure; Humans; Hypertension; Infant, Newborn; Phenethylamines; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Risk Factors; Sotalol; Sulfonamides; Survival Rate; Torsades de Pointes | 1997 |
New advances in class III antiarrhythmic drug therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2000 |
Clinical differences between the newer antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides | 2000 |
A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides | 2001 |
New antiarrhythmic drugs for the treatment of atrial fibrillation.
Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2002 |
Prevention of and medical therapy for atrial arrhythmias in heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Carbazoles; Carvedilol; Drug Therapy, Combination; Electric Countershock; Heart Failure; Humans; Pacemaker, Artificial; Phenethylamines; Propanolamines; Software Design; Sulfonamides | 2002 |
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Heart Failure; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 2002 |
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Risk Assessment; Risk Factors; Sex Factors; Sotalol; Sulfonamides; Tachycardia; Torsades de Pointes | 2003 |
Potentially significant drug interactions of class III antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Drug Interactions; Humans; Phenethylamines; Sotalol; Sulfonamides | 2003 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Indoles; Oxazines; Phenethylamines; Piperazines; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides | 2004 |
Antiarrhythmic drug therapy of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Flecainide; Humans; Phenethylamines; Sotalol; Sulfonamides | 2004 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome | 2004 |
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Failure; Humans; Incidence; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides | 2004 |
Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left | 2012 |
Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzofurans; Defibrillators, Implantable; Humans; Hydantoins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Mineralocorticoid Receptor Antagonists; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2014 |
4 trial(s) available for amiodarone and uk 68798
Article | Year |
---|---|
Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Prognosis; Sulfonamides; Vasodilator Agents | 2000 |
Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Double-Blind Method; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Long QT Syndrome; Male; Middle Aged; Myocardial Contraction; Phenethylamines; Sulfonamides; Ventricular Function, Left | 2001 |
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Calcium Channel Blockers; Combined Modality Therapy; Comorbidity; Digoxin; Electric Countershock; Follow-Up Studies; Heart Rate; Humans; Models, Cardiovascular; Myocardial Contraction; Phenethylamines; Proportional Hazards Models; Retrospective Studies; Risk; Stroke; Sulfonamides; Survival Analysis; Treatment Failure; Treatment Outcome; Warfarin | 2004 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
33 other study(ies) available for amiodarone and uk 68798
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Heart Conduction System; Hemodynamics; Humans; Male; Myocardial Contraction; Phenethylamines; Rats; Rats, Wistar; Sotalol; Sulfonamides | 1997 |
[Heart failure and sudden cardiac death: pharmacological and nonpharmacological treatment possibilities from the viewpoint of the rhythmologist].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Follow-Up Studies; Heart Failure; Humans; Multicenter Studies as Topic; Phenethylamines; Potassium Channel Blockers; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides; Vasodilator Agents | 2000 |
Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Atrial Function, Right; Flecainide; Male; Phenethylamines; Propafenone; Sulfonamides; Swine | 2001 |
Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Berberine; Calcium Channel Blockers; Female; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Papillary Muscles; Phenethylamines; Piperidines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides; Verapamil | 2001 |
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channels, L-Type; Dogs; Electrocardiography; Electrophysiology; Flecainide; Heart Atria; Phenethylamines; Refractory Period, Electrophysiological; Sulfonamides; Tachycardia | 2003 |
[Progress in the clinical use of anti-arrhythmic drugs (I)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Clinical Trials as Topic; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sulfonamides | 2003 |
Introduction--roundtable on atrial fibrillation: update on mechanisms and approaches to treatment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Humans; Palliative Care; Phenethylamines; Sulfonamides; Treatment Outcome | 2003 |
Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Atropine; Biphenyl Compounds; Chromans; Flecainide; Heart Atria; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Propafenone; Propanolamines; Sotalol; Sulfonamides; Swine; Ventricular Function | 2004 |
The influence of extracellular acidosis on the effect of IKr blockers.
Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Humans; Hydantoins; Imidazolidines; Myocardial Infarction; Oocytes; Phenethylamines; Piperazines; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Trans-Activators; Xenopus laevis | 2005 |
Use of a failing rabbit heart as a model to predict torsadogenicity.
Topics: Amiodarone; Animals; Cardiac Output, Low; Cisapride; Dose-Response Relationship, Drug; Electrocardiography; Models, Animal; Phenethylamines; Quaternary Ammonium Compounds; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Verapamil | 2006 |
Effect of atrial electrical remodeling on the efficacy of antiarrhythmic drugs: comparison of amiodarone with I(Kr)- and I(to)/IKur-blockade in vivo.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Goats; Heart Conduction System; Injections, Intravenous; Male; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Swine | 2007 |
Amiodarone and atrial fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Biphenyl Compounds; Dose-Response Relationship, Drug; Female; Goats; Heart Conduction System; Injections, Intravenous; Male; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Swine | 2007 |
Alternatives to amiodarone: search for the Holy Grail.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Combined Modality Therapy; Dose-Response Relationship, Drug; Dronedarone; Humans; Pacemaker, Artificial; Phenethylamines; Sulfonamides | 2009 |
Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure.
Topics: Amiodarone; Cohort Studies; Female; Humans; Male; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Time Factors; Treatment Failure; Treatment Outcome | 2011 |
Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
Topics: Acidosis; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Flecainide; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Patch-Clamp Techniques; Phenethylamines; Potassium; Potassium Channel Blockers; Sulfonamides; Time Factors; Transfection | 2011 |
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Dronedarone; Female; Humans; Male; Patient Admission; Pennsylvania; Phenethylamines; Recurrence; Retrospective Studies; Sotalol; Stroke; Sulfonamides | 2016 |
Antiarrhythmic effect of the Ca
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Synergism; Guinea Pigs; Heart; Heart Rate; Isolated Heart Preparation; Phenethylamines; Potassium Channel Blockers; Pyridines; Small-Conductance Calcium-Activated Potassium Channels; Sulfonamides; Thiazoles | 2016 |
Frequency of Adverse Event Monitoring in Ambulatory Patients on Amiodarone or Dofetilide.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides | 2018 |
Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter-defibrillator.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Female; Hospitalization; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides | 2019 |
Different effects of amiodarone and dofetilide on the dispersion of repolarization between well-coupled ventricular and Purkinje fibers
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Female; Heart Ventricles; Humans; Male; Microelectrodes; Models, Animal; Phenethylamines; Purkinje Fibers; Sulfonamides; Tachycardia, Ventricular | 2021 |
Comparative Efficacy of Dofetilide Versus Amiodarone in Patients With Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Phenethylamines; Stroke Volume; Sulfonamides; Ventricular Function, Left | 2021 |